Peripheral Arterial Disease and Chronic Limb Threatening Ischemia
Ferring Ventures GmbH is involved in clinical research focused on peripheral arterial disease with a specific emphasis on patients with chronic limb threatening ischemia, a severe vascular condition associated with impaired limb perfusion and difficult-to-heal tissue injury.
- Vascular insufficiency
- Limb ischemia
- Wound healing
The sponsor’s research interest centers on therapeutic approaches relevant to limb preservation and the management of ischemic tissue damage.
Wound Repair and Local Tissue Recovery
Clinical activity also reflects interest in wound repair and the restoration of damaged tissue in ischemic limbs, with attention to outcomes related to target wound size and tissue recovery.
- Non-healing wounds
- Tissue perfusion
- Ulcer care
This area highlights a therapeutic focus on conditions where compromised blood flow limits natural healing processes.
Regenerative Therapy for Ischemic Disease
The sponsor’s research landscape includes interest in regenerative therapy for ischemic disorders, with work directed toward interventions intended to support recovery in damaged limb tissue.
- Local tissue regeneration
- Ischemic injury
- Therapeutic restoration
These efforts align with medical needs in advanced vascular disease where treatment options are limited by progressive tissue loss.
Intramuscular Treatment in Vascular Complications
Research activity also covers intramuscular treatment approaches in the setting of vascular complications, indicating interest in delivery strategies aimed at affected limb regions.
- Targeted administration
- Lower limb disease
- Ischemic wound management
This therapeutic domain is centered on interventions for patients with severe circulatory impairment and associated wound burden.
